GLP1R and cardiovascular disorder: GLP-1 RAs were shown to reduce mortality and major cardiovascular events more effectively than sulfonylureas or DPP-4is in patients with established or high-risk cardiovascular disease in a meta-analysis by Brønden et al. [157].